NE
NexgenRx Inc.
NEGXF · OTC
$0.46 +6.35% (+$0.03)
1M +948.78%
Market Cap $45.2M
P/E Ratio 17.14x
Div. Yield 3.19%
ROE 30.87%
Bulios Fair Price
$0.69
50.9% upside
Current Price
$0.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NEGXF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
80 /100
Cheap EV/EBITDA 1.59x
P/S 2.37x
P/B 4.81x
Growth
59 /100
Stable Book val. growth 4.61%
Rev. growth 11.90%
FCF growth N/A
Profitability
59 /100
Moderate Net margin 13.84%
Op. margin 18.11%
FCF margin 8.95%
Quality
84 /100
Excellent ROE 30.87%
ROA 5.73%
Asset turnover 0.41x
Debt
92 /100
Low Current ratio 1.15x
Int. coverage 19.97x
Net debt/EBITDA -8.47x
Stability
54 /100
Moderate Rev. volatility 6.55%
EPS volatility 1,061.97%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NEGXF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ronald C. Loucks
Employees
20
Headquarters
Toronto